These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23756691)

  • 1. Epigenetic mechanisms in cerebral ischemia.
    Schweizer S; Meisel A; Märschenz S
    J Cereb Blood Flow Metab; 2013 Sep; 33(9):1335-46. PubMed ID: 23756691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of Epigenetics in Cerebral Ischemia.
    Hu Z; Zhong B; Tan J; Chen C; Lei Q; Zeng L
    Mol Neurobiol; 2017 Apr; 54(3):1887-1905. PubMed ID: 26894397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
    Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.
    Fessler EB; Chibane FL; Wang Z; Chuang DM
    Curr Pharm Des; 2013; 19(28):5105-20. PubMed ID: 23448466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models.
    Jhelum P; Karisetty BC; Kumar A; Chakravarty S
    Curr Neuropharmacol; 2017; 15(6):815-830. PubMed ID: 27964703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
    Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
    Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
    Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases in stroke.
    Kao MH; Lin TN
    Chin J Physiol; 2019; 62(3):95-107. PubMed ID: 31249263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC Inhibitor Sodium Butyrate-Mediated Epigenetic Regulation Enhances Neuroprotective Function of Microglia During Ischemic Stroke.
    Patnala R; Arumugam TV; Gupta N; Dheen ST
    Mol Neurobiol; 2017 Oct; 54(8):6391-6411. PubMed ID: 27722928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia.
    Ziemka-Nalecz M; Zalewska T
    Acta Neurobiol Exp (Wars); 2014; 74(4):383-95. PubMed ID: 25576969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
    Kim TK; Gore SD; Zeidan AM
    Semin Hematol; 2015 Jul; 52(3):172-83. PubMed ID: 26111464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
    Terui Y
    Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC4 in ischemic stroke: mechanisms and therapeutic potential.
    Kong Q; Hao Y; Li X; Wang X; Ji B; Wu Y
    Clin Epigenetics; 2018 Sep; 10(1):117. PubMed ID: 30208931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer.
    Bai Y; Ahmad D; Wang T; Cui G; Li W
    Curr Top Med Chem; 2019; 19(12):995-1004. PubMed ID: 30686256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
    Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
    Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between mitochondrial metabolism and oxidative stress in ischemic stroke: An epigenetic connection.
    Narne P; Pandey V; Phanithi PB
    Mol Cell Neurosci; 2017 Jul; 82():176-194. PubMed ID: 28552342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.